Vaccination and Antiviral Treatment of Neglected Diseases Caused by Flaviviral Infections
Keywords: Aedes aegypti; Aedes albopictus; Aedes mosquitoes; Artemisia vulgaris; Chimeric LAVs; Culex tritaeniosphynchus; DENGUE VACCINE; Dengue Fever; ENDOPLASMATIC RETICU-LUM STRESS; Flaviviral infections; Flaviviral methyltransferases; Flaviviridae family; IMMUNE SYSTEM; Ixodes persulcatus; JAK-STAT SIGNALING PATH-WAY; Japanese Encephalitis; Lippia alba; Lippia origanoides; NITRIC OXIDE; NON-REPLICATING VACCINES; NS1; NS2A; NS2B; NS5 protein; NTPase; Oreganum vulgare; Recombinant LAVs; Vaccination; Viremia titers; World Health Organization; Yellow fever; antibodies; antibody-dependent enhancement; capsid protein (C); chimeras; colloid solutions; crystalloid; cyclophilins; dendritic cells; envelope protein (E); favipiravir; helicase; hemorrhagic fever; inosine monophosphate dehydrogenase (IMPDH); live attenuated vaccines; macrophages; membrane protein (prM/M); monocytes; open reading frame; peptidyl-prolyl isomerases; primary dog kidney (PDK); pyrazine carboxamide derivatives; recombinant vaccines; serine protease; signal transduction; sylvatic cycles; tetravalent vaccines; tick-borne encephalitis; triphosphatase; viral peptide inhibitors; xanthosine monophosphate; xodes ricinus
Document Type: Research Article
Publication date: 01 February 2011
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content